Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Botulinum toxin type B for cervical dystonia

This is not the most recent version

view the current version 13 May 2016

Information

DOI:
https://doi.org/10.1002/14651858.CD004315.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 18 October 2004see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:

  1. Cochrane Movement Disorders Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • João Costa

    Correspondence to: Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

    [email protected]

  • Cláudia C Espírito‐Santo

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Ana A Borges

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Joaquim Ferreira

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Miguel M Coelho

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

  • Peter Moore

    The Walton Centre for Neurology and Neurosurgery, NHS Trust, Liverpool, UK

  • Cristina Sampaio

    Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina de Lisboa, Lisboa, Portugal

Contributions of authors

Protocol ‐ Costa J, Ferreira JJ, Sampaio C
Literature search ‐ Costa J, Borges A, Espírito‐Santo C
Literature selection ‐ Costa J, Borges A, Espírito‐Santo C
Papers quality assessment ‐ Costa J, Miguel C
Data collection from papers ‐ Costa J, Miguel C
Interpretation of data ‐ Costa J, Ferreira JJ, Moore P, Sampaio C
Review writing ‐ Costa J, Ferreira JJ, Moore, Sampaio C

Sources of support

Internal sources

  • Cochrane Movement Disorders Group, Portugal.

  • The Walton Centre for Neurology and Neurosurgery, UK.

External sources

  • No sources of support supplied

Declarations of interest

available in

Costa J, Ferreira JJ, Sampaio C, and Miguel C had been investigators in clinical trials sponsored by Elan, Allergan, and Ipsen. Ferreira JJ and Sampaio C were speakers in symposia promoted by Elan, Allergan, and Ipsen.
Moore P has received fees from various companies marketing botulinum toxin for speaking at meetings and for advice. His unit has received funds for research.

Version history

Published

Title

Stage

Authors

Version

2016 May 13

Botulinum toxin type B for cervical dystonia

Review

Raquel E Marques, Gonçalo S Duarte, Filipe B Rodrigues, Mafalda Castelão, Joaquim Ferreira, Cristina Sampaio, A Peter Moore, João Costa

https://doi.org/10.1002/14651858.CD004315.pub3

2004 Oct 18

Botulinum toxin type B for cervical dystonia

Review

João Costa, Cláudia C Espírito‐Santo, Ana A Borges, Joaquim Ferreira, Miguel M Coelho, Peter Moore, Cristina Sampaio

https://doi.org/10.1002/14651858.CD004315.pub2

2003 Jul 21

Botulinum toxin type B for cervical dystonia

Protocol

João Costa, Cláudia C Espírito‐Santo, Ana A Borges, Joaquim Ferreira, Miguel M Coelho, Peter Moore, Cristina C Sampaio

https://doi.org/10.1002/14651858.CD004315

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.